We came across a bullish thesis on Niagen Bioscience, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on NAGE. Niagen Bioscience, Inc.’s share was trading at $65.99 as of January 29th. NAGE’s trailing and forward P/E were 24.96 and 19.96 respectively according to Yahoo Finance.

Pressmaster/Shutterstock.com
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. NAGE formerly ChromaDex,...